NexLife Review 2026: Pricing, Services and Safety

NexLife advertises online provider-reviewed weight care with compounded semaglutide and tirzepatide, support and shipping. The lowest monthly-equivalent rate requires a prepaid 12-month plan. Compounded GLP-1s are not FDA-approved; current federal compounding rules require an individualized legal basis.

By NexLife Written by TirzaSema Editorial Team Fact-checked Updated
NexLife logo

Quick verdict

Independent review of

NexLife nexlife.com

  • No affiliate relationship
  • Compounded medication: not FDA-approved
Official site ↗
Best for
adults seeking online weight care who want published bundled rates and are prepared to verify legal, clinical and pharmacy details before purchase
Key feature
direct-to-consumer telehealth platform marketing compounded GLP-1 weight-loss plans

NexLife advertises online provider-reviewed weight care with compounded semaglutide and tirzepatide, support and shipping. The lowest monthly-equivalent rate requires a prepaid 12-month plan. Compounded GLP-1s are not FDA-approved; current federal compounding rules require an individualized legal basis. The lowest advertised monthly equivalent relies on a year-long prepayment. Trustpilot feedback for nexlife.us is positive overall but includes critical reports about delayed or warm shipments and customer-support problems. Reviews are self-reported experiences, not evidence of drug quality or clinical benefit.

Our rating

  • Cost and price transparency6.0/ 10

    Published prices, total charge and billing terms.

  • Medication options and sourcing3.0/ 10

    Treatment type, medication status and pharmacy information.

  • Medical care and safety5.0/ 10

    Clinician involvement and transparent safety disclosures; not treatment efficacy.

  • Ease of use and access6.0/ 10

    Eligibility, enrollment, geographic availability and benefit access.

  • Customer support and policies6.0/ 10

    Policy clarity and available broad customer feedback.

How this score is calculated

Each category score is converted to a percentage and multiplied by its weight. The overall score is the sum of those contributions.

CategoryScoreWeightContribution
Cost and price transparency6.0 / 1030.0%1.8
Medication options and sourcing3.0 / 1020.0%0.6
Medical care and safety5.0 / 1020.0%1.0
Ease of use and access6.0 / 1015.0%0.9
Customer support and policies6.0 / 1015.0%0.9
Overall5.2 / 10

Pricing

Starting price

See details
  • From $119/month equivalent on a 12-month semaglutide plan; annual billing is $1,428. Month-to-month pricing shown on NexLife’s treatment page is $139/month. Tirzepatide prices vary by term.
Check current terms

Prices can change. Check the official site for current details. Last checked September 24, 2026.

Pros and cons

Pros

  • Published plan and membership pricing, with a month-to-month option shown
  • Online intake, provider review and support are described
  • Trustpilot profile has a moderate number of reviews and generally positive feedback

Cons

  • Lowest price requires a full-year prepaid commitment
  • Compounded medication is not FDA-approved; verify the specific legal and clinical basis
  • Two NexLife domains are used; confirm the exact contracting entity, pharmacy and terms

Features

Service at a glancedirect-to-consumer telehealth platform marketing compounded GLP-1 weight-loss plans
Published plan and membership pricing, with a month-to-month option shown
Online intake, provider review and support are described
Trustpilot profile has a moderate number of reviews and generally positive …Trustpilot profile has a moderate number of reviews and generally positive feedback

Specifications

NexLife provider-reviewed weight-management plan specifications
Service typeOnline weight-loss and GLP-1 care at nexlife.com
Medication typeCompounded GLP-1s, which are not FDA-approved
PricingPublished charges are described in the Pricing section. Confirm the selected treatment, billing term and total at checkout.
Trustpilot4.8 / 5 from 308 reviews
Our takeNexLife advertises online provider-reviewed weight care with compounded semaglutide and tirzepatide, support and shippin…
Data statusAwaiting a verified price check

Full review

Price not currently verified

Our score
5.2/10
Best for
adults seeking online weight care who want published bundled rates and are prepared to verify legal, clinical and pharmacy details before purchase
Starting price
From $119/month equivalent on a 12-month semaglutide plan; annual billing is $1,428. Month-to-month pricing shown on NexLife’s treatment page is $139/month. Tirzepatide prices vary by term.
Trustpilot
4.8/5; 308 Trustpilot reviews

Quick verdict

NexLife advertises online provider-reviewed weight care with compounded semaglutide and tirzepatide, support and shipping. The lowest monthly-equivalent rate requires a prepaid 12-month plan. Compounded GLP-1s are not FDA-approved; current federal compounding rules require an individualized legal basis. The lowest advertised monthly equivalent relies on a year-long prepayment. Trustpilot feedback for nexlife.us is positive overall but includes critical reports about delayed or warm shipments and customer-support problems. Reviews are self-reported experiences, not evidence of drug quality or clinical benefit. This is an editorial review of publicly available information; we did not purchase care or test medication. The score measures published pricing, access, service transparency, and customer feedback—not clinical effectiveness.

What the service offers

NexLife’s public pages describe online intake, provider review, prescription management when clinically appropriate and pharmacy coordination. The company advertises support and coaching. Its pages present monthly equivalents that depend on the selected term; the 12-month semaglutide plan is billed annually, not monthly.

The provider, not the marketing page, must determine whether treatment is clinically appropriate. NexLife’s FAQ says compounded products are not FDA-approved. FDA says semaglutide and tirzepatide are not on its current drug-shortage or 503B bulks lists and that compounding is subject to specific statutory conditions. Before enrolling, ask the prescriber to explain the individualized medical need, exact formulation, dispensing pharmacy and adverse-event contact.

Pricing and what is included

From $119/month equivalent on a 12-month semaglutide plan; annual billing is $1,428. Month-to-month pricing shown on NexLife’s treatment page is $139/month. Tirzepatide prices vary by term. The table below separates advertised monthly equivalents from the terms that affect the actual amount paid. Promotion pages and plan menus can change. Check the exact prescription, supply period, full payment, renewal schedule, shipping and refund terms before checkout.

Plan or item Published price Important detail
Semaglutide, annual $119/mo equivalent; $1,428 upfront 12-month plan
Semaglutide, monthly $139/month shown on plan page Confirm current checkout
Tirzepatide Term-dependent Confirm full order total

NexLife states its 12-month semaglutide plan is $119 per month equivalent ($1,428 upfront), with shorter terms priced higher. A separate checkout page shows $139 month to month. Verify which NexLife site and exact plan applies: the Trustpilot profile is for nexlife.us while this directory entry links to nexlife.com. Terms describe cancellation/refund calculations for unshipped portions; read them before paying.

Eligibility, clinicians and access

Confirm service availability in your state, who provides the service or makes treatment decisions, what clinical follow-up is included, and how to reach a clinician for medical questions. Benefit rules, state availability and eligibility can change. Completing an intake or payment does not guarantee that a prescription or service will be provided.

Treatment and safety considerations

The provider, not the marketing page, must determine whether treatment is clinically appropriate. NexLife’s FAQ says compounded products are not FDA-approved. FDA says semaglutide and tirzepatide are not on its current drug-shortage or 503B bulks lists and that compounding is subject to specific statutory conditions. Before enrolling, ask the prescriber to explain the individualized medical need, exact formulation, dispensing pharmacy and adverse-event contact.

For compounded medication, FDA notes that compounding is not a substitute for FDA approval: compounded drugs are not reviewed for safety, effectiveness or quality before marketing. Federal and state rules limit when compounding is permitted. If a service offers compounded semaglutide or tirzepatide, ask the prescriber to explain the patient-specific medical need and the dispensing pharmacy. Never change a prescribed dose based on website copy or customer reviews.

Pros and cons

Pros

  • Published plan and membership pricing, with a month-to-month option shown
  • Online intake, provider review and support are described
  • Trustpilot profile has a moderate number of reviews and generally positive feedback

Cons

  • Lowest price requires a full-year prepaid commitment
  • Compounded medication is not FDA-approved; verify the specific legal and clinical basis
  • Two NexLife domains are used; confirm the exact contracting entity, pharmacy and terms

Our rating

We weight price transparency at 30%, medication or product clarity at 20%, medical care and safety disclosures at 20%, access at 15%, and support and policy clarity at 15%. The weighted score is 5.2/10. It is an editorial comparison score, not a clinical rating.

Category Score What we assessed
Cost and price transparency 6/10 Published prices, total charge and billing terms.
Medication options and sourcing 3/10 Treatment type, medication status and pharmacy information.
Medical care and safety 5/10 Clinician involvement and transparent safety disclosures; not treatment efficacy.
Ease of use and access 6/10 Eligibility, enrollment, geographic availability and benefit access.
Customer support and policies 6/10 Policy clarity and available broad customer feedback.

Customer feedback

4.8out of 5 on Trustpilot308 reviews, checked 2026-09-24

What customers praise

  • Customers often discuss response times, enrollment and delivery.

What customers complain about

  • Some reviewers report service or fulfillment concerns; feedback is self-reported and not clinical evidence.

Customer reviews describe individual service experiences. They are not medical evidence.

The profile is for nexlife.us, not the directory-listed nexlife.com. Reviewers often praise responsiveness and price; some report shipping-temperature, delivery or support problems. Trustpilot comments are not clinical or quality verification. Read the profile directly to see the full range of recent comments. Reviews reflect individual experiences and do not verify a prescription, medication quality or expected result.

How it compares

Decision point NexLife What to compare
Access direct-to-consumer telehealth platform marketing compounded GLP-1 weight-loss plans Check whether direct enrollment or an employer benefit is required.
Price From $119/month equivalent on a 12-month semaglutide plan; annual billing is $1,428. Month-to-month pricing shown on NexLife’s treatment page is $139/month. Tirzepatide prices vary by term. Compare the actual full charge and treatment supply, not only the monthly equivalent.
Clinical pathway See provider/process details above Identify the treating clinician, pharmacy and follow-up route.
Customer feedback 4.8/5; 308 Trustpilot reviews Check the profile size, recency, scope and unresolved complaints.

For comparison, an employer-covered program such as Omada works differently from a direct-to-consumer medication plan. A branded OTC medicine such as alli is also not interchangeable with a telehealth prescription service. Match the care model to your needs and confirm options with a qualified clinician.

Frequently asked questions

What does NexLife cost?

NexLife advertises semaglutide from $119 per month equivalent on a 12-month plan billed $1,428 upfront; a separate page lists $139 month-to-month. Confirm the live checkout total.

Are NexLife’s compounded medicines FDA-approved?

No. NexLife states compounded medication is not FDA-approved. FDA restrictions and individual medical-need requirements apply.

Can anyone get a prescription?

No. A licensed provider must assess each person and may decide against prescribing.

What do Trustpilot reviews cover?

The 4.8 score and 308 reviews found were for nexlife.us. Feedback concerns customer experience and cannot confirm product quality or clinical effect.

Sources

We checked official service, pricing and policy pages and the linked public feedback profile where available on September 24, 2026. The company’s own claims are identified as claims; customer reviews are presented as individual feedback.

How we researched and scored

We reviewed the linked brand pages, current pricing and FAQ pages, terms where available, regulatory statements and the matching Trustpilot profile. We compared published facts rather than conducting a clinical trial or mystery-shopper purchase. Prices, benefit availability, state coverage and product offerings can change. The score is based on the published criteria shown above and should not be read as a medical recommendation.

Final verdict

NexLife advertises online provider-reviewed weight care with compounded semaglutide and tirzepatide, support and shipping. The lowest monthly-equivalent rate requires a prepaid 12-month plan. Compounded GLP-1s are not FDA-approved; current federal compounding rules require an individualized legal basis. The lowest advertised monthly equivalent relies on a year-long prepayment. Trustpilot feedback for nexlife.us is positive overall but includes critical reports about delayed or warm shipments and customer-support problems. Reviews are self-reported experiences, not evidence of drug quality or clinical benefit. Before enrolling or purchasing, verify the current full price, treatment and terms directly with the company and discuss medical questions with a licensed healthcare professional.

Alternatives

Trimi logo
Editor's choice

Trimi offers online provider review and bundled compounded GLP-1 plans. Its lowest advertised monthly rates require substantial prepaid commitments. Trustpilot currently displays a guidelines-breach…

September 24, 2026 7.9/10

Frequently asked questions

NexLife advertises semaglutide from $119 per month equivalent on a 12-month plan billed $1,428 upfront; a separate page lists $139 month-to-month. Confirm the live checkout total.

No. NexLife states compounded medication is not FDA-approved. FDA restrictions and individual medical-need requirements apply.

No. A licensed provider must assess each person and may decide against prescribing.

The 4.8 score and 308 reviews found were for nexlife.us. Feedback concerns customer experience and cannot confirm product quality or clinical effect.

Sources

  1. NexLife current home page nexlife.com · checked September 24, 2026
  2. NexLife treatment pricing nexlife.us · checked September 24, 2026
  3. NexLife FAQ nexlife.us · checked September 24, 2026
  4. NexLife terms and cancellation www.nexlife.com · checked September 24, 2026
  5. FDA policy for GLP-1 compounding www.fda.gov · checked September 24, 2026
  6. Trustpilot NexLife profile www.trustpilot.com · checked September 24, 2026

How we test

TirzaSema GLP-1 Provider Scoring Methodology

This methodology explains how TirzaSema scores GLP-1 telehealth providers and programs. Scores are a weighted average of five categories, and every review shows the full breakdown. Affiliate relationships and commission rates are not part of the methodology.

  • Cost and price transparency (30%): total monthly cost at common doses, including membership, consultation and shipping fees, and how clearly this is shown before payment.
  • Medication options and sourcing (20%): FDA-approved brand-name and/or compounded options, how clearly compounded products are labeled, and dispensing-pharmacy information.
  • Medical care and safety (20%): eligibility assessment, licensed-clinician review, dose and side-effect monitoring, and follow-up care.
  • Ease of use and access (15%): sign-up process, time to treatment, states served, and insurance support.
  • Customer support and policies (15%): responsiveness, cancellation and refund terms, auto-renewal clarity, and patterns in public customer feedback.

We research prices using provider and manufacturer public pages. Where published, we separate medication, membership, consultation and shipping charges, note dose or term differences, and label introductory offers. Each review states when its sources were checked. We have not enrolled in or bought a service unless that specific review explicitly describes hands-on testing. Confirm current terms and eligibility with the provider.

FDA-approved medications are reference entries with their labeled uses and official manufacturer information; our provider ratings do not measure a treatment’s clinical effectiveness.

Some links on TirzaSema are affiliate links. Commissions never affect scores, rankings, pros and cons, or medical and regulatory information. See our Affiliate Disclosure.

Read the full methodology

Final verdict

NexLife advertises online provider-reviewed weight care with compounded semaglutide and tirzepatide, support and shipping. The lowest monthly-equivalent rate requires a prepaid 12-month plan. Compounded GLP-1s are not FDA-approved; current federal compounding rules require an individualized legal basis. The lowest advertised monthly equivalent relies on a year-long prepayment. Trustpilot feedback for nexlife.us is positive overall but includes critical reports about delayed or warm shipments and customer-support problems. Reviews are self-reported experiences, not evidence of drug quality or clinical benefit.

NexLife provider-reviewed weight-management plan

Check current details
T
Written by

TirzaSema Editorial Team

Research and editorial team

The TirzaSema Editorial Team researches U.S. GLP-1 prices and telehealth programs using official manufacturer, FDA and provider sources. Every review states whether it is based on hands-on testing or on research of public information,…